Effect of Low-Dose Mulberry Fruit Extract on Postprandial Glucose and Insulin Responses: A Randomized Pilot Trial in Individuals with Type 2 Diabetes

被引:0
|
作者
Mela, David J. [1 ]
Alssema, Marjan [1 ,3 ]
Hiemstra, Harry [1 ]
Hoogenraad, Anne-Roos [1 ]
Kadam, Tanvi [2 ]
机构
[1] Unilever Foods Innovat Ctr Wageningen, NL-6708 WH Wageningen, Netherlands
[2] Unilever Res India, Mumbai 400099, India
[3] Hlth Council Netherlands, NL-2594 AV The Hague, Netherlands
关键词
alpha-glucosidase; 1-deoxynojirimycin; glycemic control; starch; rice; GLYCEMIC INDEX; LEAF EXTRACT; BLOOD-GLUCOSE; METAANALYSIS; MANAGEMENT; IMPACT;
D O I
10.3390/nu16142177
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Adding mulberry fruit extract (MFE) to carbohydrate-rich meals can reduce postprandial glucose (PPG) and insulin (PPI) responses in healthy individuals. This pilot study assessed the acute postprandial effects of low doses of MFE in individuals with type 2 diabetes. In a randomized cross-over (within-subjects) design, 24 unmedicated adult males and females with type 2 diabetes (mean [SD] age 51.0 [9.3] yr, BMI 27.5 [3.9] kg/m(2)) consumed meals with 0 (control), 0.37, and 0.75 g of MFE added to similar to 50 g of available carbohydrates from rice. Primary and secondary outcomes were the PPG 2 hr positive incremental area under the curve and the corresponding PPI. Results were reported as mean differences from the control meal with 95% CI. Relative to control, 0.37 and 0.75 g of MFE reduced the mean 2 hr PPG by 8.2% (-20.8 to 6.6%) and 22.4% (-38.6 to -1.9%), respectively, and reduced PPI by 9.6% (-20.7 to 3.0%) and 17.5% (-27.9 to -5.7%). There were no indications of adverse events or gastrointestinal discomfort. MFE additions also led to dose-related reductions in glucose peak and glucose swing. At these levels, MFE appears to dose-dependently reduce acute PPG and PPI in individuals with type 2 diabetes and may be a feasible dietary approach to help attenuate glycemic exposures.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Ethanol Impairs the Glucose-Restoring Effect of Low-Dose Glucagon in Patients with Type 1 Diabetes
    Ranjan, Ajenthen
    Tetzschner, Rikke
    Steineck, Isabelle
    Madsbad, Sten
    Holst, Jens Juul
    Norgaard, Kirsten
    Schmidt, Signe
    DIABETES, 2017, 66 : A352 - A352
  • [42] Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial
    Rasouli, Neda
    Younes, Naji
    Ghosh, Alokananda
    Albu, Jeanine
    Cohen, Robert M.
    DeFronzo, Ralph A.
    Diaz, Elsa
    Kassem, Laure Sayyed
    Luchsinger, Jose A.
    McGill, Janet B.
    Sivitz, William I.
    Tamborlane, William V.
    Utzschneider, Kristina M.
    Kahn, Steven E.
    DIABETES CARE, 2024, 47 (04) : 580 - 588
  • [43] A Single Sauna Session Does Not Improve Postprandial Blood Glucose Handling in Individuals with Type 2 Diabetes Mellitus: A Cross-Over, Randomized, Controlled Trial
    Schenaarts, Laura
    Hendriks, Floris K.
    Fuchs, Cas J.
    Sluijsmans, Wendy E. M.
    Snijders, Tim
    van Loon, Luc J. C.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2024, 132 (11) : 622 - 630
  • [44] Fructose decreases the glucose and insulin responses to an oral glucose tolerance test (OGTT) in individuals with type 2 diabetes (DM2)
    Moore, MC
    Mann, SL
    Converse, M
    Penaloza, A
    DIABETES, 2000, 49 : A84 - A84
  • [45] Fasting Until Noon Triggers Increased Postprandial Hyperglycemia and Impaired Insulin Response After Lunch and Dinner in Individuals With Type 2 Diabetes: A Randomized Clinical Trial
    Jakubowicz, Daniela
    Wainstein, Julio
    Ahren, Bo
    Landau, Zohar
    Bar-Dayan, Yosefa
    Froy, Oren
    DIABETES CARE, 2015, 38 (10) : 1820 - 1826
  • [46] Dietary protein affects both the dose and pattern of insulin delivery required to achieve postprandial euglycaemia in Type 1 diabetes: a randomized trial
    Evans, M.
    Smart, C. E. M.
    Paramalingam, N.
    Smith, G. J.
    Jones, T. W.
    King, B. R.
    Davis, E. A.
    DIABETIC MEDICINE, 2019, 36 (04) : 499 - 504
  • [47] Effect of glycine on insulin secretion, fasting and postprandial glucose levels in patients with Type 2 diabetes mellitus.
    Martínez-Abundis, E
    Kam-Ramos, AM
    Hernández-Salazar, E
    González-Ortiz, M
    DIABETOLOGIA, 2003, 46 : A261 - A262
  • [48] The Effect of Low-Dose Empagliflozin on Glucose Control in Suboptimally Controlled Adults with Type 1 Diabetes on a Closed-Loop Insulin Delivery System
    Pasqua, Melissa-Rosina
    Jafar, Adnan
    Kobayati, Alessandra
    Tsoukas, Michael
    Haidar, Ahmad
    DIABETES, 2022, 71
  • [49] Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial
    Battelino, Tadej
    Nimri, Revital
    Dovc, Klemen
    Phillip, Moshe
    Bratina, Natasa
    DIABETES CARE, 2017, 40 (06) : 764 - 770
  • [50] Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial
    Rayner, Christopher K.
    Watson, Linda E.
    Phillips, Liza K.
    Lange, Kylie
    Bound, Michelle J.
    Grivell, Jacqueline
    Wu, Tongzhi
    Jones, Karen L.
    Horowitz, Michael
    Ferrannini, Ele
    Trico, Domenico
    Frascerra, Silvia
    Mari, Andrea
    Natali, Andrea
    DIABETES CARE, 2020, 43 (08) : 1813 - 1821